Status:
UNKNOWN
The Therapeutic Effect of Dysthyroid Optic Neuropathy
Lead Sponsor:
Sun Yat-sen University
Conditions:
Thyroid Eye Disease
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Thyroid associated ophthalmopathy (TAO) is a common autoimmune disorder. The pathogenesis of TAO is unclear, and studies found that T cell, B cell and monocytes, macrophages and mast cells are located...
Eligibility Criteria
Inclusion
- \- Ability to perform visual fields and VEP examination Without any serious systemic diseases Without any surgery on eyes in six months
Exclusion
- \- With any serious systemic diseases With any surgery on eyes in six months
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04096612
Start Date
January 1 2016
End Date
December 31 2019
Last Update
September 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Opthalmic Center
Guangdong, Guangdong, China, 510060